Clinical Trial Update: Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane [NA]

View source ↗

Summary

The clinical trial evaluating dexamethasone intravitreal implant after vitrectomy for epiretinal membrane was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epiretinal Membrane
• Macular Edema

Drugs mentioned

• Dexamethasone Intravitreal Implant (Ozurdex) (dexamethasone intravitreal implant)

Snippet

Sponsor: Barnes Retina Institute | Conditions: Epiretinal Membrane, Macular Edema | NA | Status: TERMINATED